Europe Clinical Trial Imaging Market – Industry Trends and Forecast to 2026

Europe Clinical Trial Imaging Market – Industry Trends and Forecast to 2026

Short Description

By Product & Services (Services, Software), Modality (Computed Tomography, Magnetic Resonance Imaging, Echocardiography, Nuclear Medicine, Positron Emission Tomography, X-Ray, Ultrasound, Optical Coherence Tomography, Others), Application (Oncology, Neurology, Endocrinology, Cardiology, Dermatology, Hematology, Others), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic and Government Research Institutes, Medical Device Manufacturers, Others), Distribution Channel (Direct Sales, Tender Sales), Country (Germany, France, U.K., Italy, Spain, Switzerland, Russia, Netherlands, Turkey, Belgium, Rest of Europe)
Market Definition:
Clinical trial is a process of developing new drugs. It is designed for potential treatment and its effects on humans. Before the commercialization of new drugs, an extensive clinical testing is done in order to identify promising compounds and safety tests are conducted to determine the possible risks. In clinical trial, medical imaging plays a significant role for more accurate and effective results. Different imaging technologies may be used to elucidate and demonstrate the mechanistic actions of drugs. Clinical trial imaging is the process for clinical analysis and medical intervention by creating image representations of the inner parts of the body. It has several different technologies which are used to view the human body in order to monitor, treat and diagnose the medical conditions. Those technologies are:

• Ultrasound imaging
• MRI (Magnetic Resonance Imaging)
• Pediatric X-ray imaging
• Medical X-ray imaging
• Echocardiography
• Nuclear medicine

Imaging is a critical and complex component of many clinical trials. Endpoints of imaging require accurate, high quality and predictive data to be successful. Medical imaging is used to prevent, detect, treat and manage various medical diseases.
Market Segmentation:
Europe clinical trial imaging market is segmented into five notable segments which are basis of product & services, modality, application, end user and distribution channel.
• On the basis of product & services, the market is segmented into services and software
• On the basis of Modality, the market is segmented into computed tomography, magnetic resonance imaging, echocardiography, nuclear medicine, positron emission tomography, x-ray, ultrasound, optical coherence tomography and others
• On the basis of application, the market is segmented into oncology, neurology, endocrinology, cardiology, dermatology, hematology and others
• On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, contract research organizations, academic and government research institutes, medical device manufacturers and others
• On the basis of distribution channel, the market is segmented into direct sales and tender sales
Market Players
The key market players for Europe clinical trial imaging market are listed below:
• BioTelemetry, Inc,
• IXICO plc
• Resonance Health
• Bioclinica, ICON plc
• Radiant Sage LLC
• Lyscaut Medical Imaging Company
• Quotient Sciences
• worldcare Clinical
• Navitas Life Sciences
• Cardiovascular Imaging Technologies
• Intrinsic Imaging
• Image Core Lab
• ERT Clinical
• Perspectum Diagnostics
• Anagram 4 clinical trials
• Parexel International Corporation

The single user license is non-downloadable and non-printable. Global Site license allows these actions.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Europe Clinical Trial Imaging Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Europe Clinical Trial Imaging Market: Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Primary Interviews With Key Opinion Leaders
2.7 Europe Clinical Trial Imaging Market: Dbmr Market Position Grid
2.8 Dbmr Vendor Share Analysis
2.9 Multivariate Modeling
2.10 Products Lifeline Curve
2.11 Secondary Sources
2.12 Assumptions
3 Market Overview
3.1 Drivers
3.1.1 Rising R&D Expenditure
3.1.2 Increasing Number Of Contract Research Organization
3.1.3 Increasing Prevalence Of Chronic Diseases
3.1.4 Growth In The Pharmaceutical And Biotechnology Industries
3.2 Restraints
3.2.1 High Risk Radiation Causing Diseases
3.2.2 High Implementation Cost Of Imaging Systems
3.3 Opportunities
3.3.1 Strategic Initiatives For Business Expansion
3.3.2 Development Of Innovative Imaging Modalities And Contrast Agents
3.3.3 Emerging Economies
3.4 Challenges
3.4.1 Strict Regulatory Policies
3.4.2 Cost Of Clinical Trials
4 Executive Summary
5 Premium Insights
6 Europe Clinical Trial Imagingmarket, By Product And Services
6.1 Overview
6.2 Services
6.2.1 Operational Imaging Services
6.2.2 Read Analysis Services
6.2.3 Trial Design Consulting Services
6.2.4 System And Technical Support Services
6.3 Software
7 Europe Clinical Trial Imaging Market, By Application
7.1 Overview
7.2 Oncology
7.2.1 Echocardiography
7.2.2 Magnetic Resonance Imaging
7.2.3 Computed Tomography
7.2.4 Positron Emission Tomography
7.2.5 Nuclear Medicine
7.2.6 X-ray
7.2.7 Ultrasound
7.2.8 Optical Coherence Tomography
7.2.9 Others
7.3 Neurology
7.3.1 Computed Tomography
7.3.2 Magnetic Resonance Imaging
7.3.3 Positron Emission Tomography
7.3.4 Nuclear Medicine
7.3.5 X-ray
7.3.6 Ultrasound
7.3.7 Optical Coherence Tomography
7.3.8 Others
7.4 Endocrinology
7.4.1 Computed Tomography
7.4.2 Magnetic Resonance Imaging
7.4.3 Positron Emission Tomography
7.4.4 Nuclear Medicine
7.4.5 X-ray
7.4.6 Ultrasound
7.4.7 Optical Coherence Tomography
7.4.8 Others
7.5 Cardiology
7.5.1 X-ray
7.5.2 Ultrasound
7.5.3 Computed Tomography
7.5.4 Magnetic Resonance Imaging
7.5.5 Nuclear Medicine
7.5.6 Positron Emission Tomography
7.5.7 Optical Coherence Tomography
7.5.8 Echocardiography
7.5.9 Others
7.6 Dermatology
7.6.1 Ultrasound
7.6.2 X-ray
7.6.3 Magnetic Resonance Imaging
7.6.4 Computed Tomography
7.6.5 Optical Coherence Tomography
7.6.6 Positron Emission Tomography
7.6.7 Nuclear Medicine
7.6.8 Others
7.7 Hematology
7.7.1 Ultrasound
7.7.2 Computed Tomography
7.7.3 Magnetic Resonance Imaging
7.7.4 X-ray
7.7.5 Positron Emission Tomography
7.7.6 Nuclear Medicine
7.7.7 Optical Coherence Tomography
7.7.8 Echocardiography
7.7.9 Others
8 Europe Clinical Trial Imagingmarket, By Modality
8.1 Overview
8.2 Computed Tomography
8.3 Magnetic Resonance Imaging
8.4 Ultrasound
8.5 Positron Emission Tomography
8.6 X-ray
8.7 Echocardiography
8.8 Nuclear Medicine
8.9 Optical Coherence Tomography
8.10 Others
9 Europe Clinical Trial Imagingmarket, By End User
9.1 Overview
9.2 Contract Research Organization
9.3 Medical Device Manufacturers
9.4 Pharmaceutical & Biotechnology Companies
9.5 Academic And Government Research Institutes
10 Europe Clinical Trial Imaging Market, By Distributor
10.1 Overview
10.2 Direct Sales
10.3 Tenders Sales
11 Europe Clinical Trial Imaging Market, By Geography
11.1 Europe
11.1.1 Germany
11.1.2 France
11.1.3 U.K.
11.1.4 Italy
11.1.5 Spain
11.1.6 Switzerland
11.1.7 Russia
11.1.8 Netherlands
11.1.9 Belgium
11.1.10 Turkey
11.1.11 Rest Of Europe
12 Europe Clinical Trial Imaging Market, Company Landscape
12.1 Company Share Analysis: Europe
13 Company Profile
13.1 Navitas Life Sciences
13.1.1 Company Snapshot
13.1.2 Revenue Analysis
13.1.3 Company Share Analysis
13.1.4 Service Portfolio
13.1.5 Recent Developments
13.2 Resonance Health
13.2.1 Company Snapshot
13.2.2 Revenue Analysis
13.2.3 Company Share Analysis
13.2.4 Service Portfolio
13.2.5 Recent Developments
13.3 Biotelemetry, Inc.
13.3.1 Company Snapshot
13.3.2 Revenue Analysis
13.3.3 Company Share Analysis
13.3.4 Serviceportfolio
13.3.5 Recent Developments
13.4 Ixico Plc
13.4.1 Company Snapshot
13.4.2 Revenue Analysis
13.4.3 Company Share Analysis
13.4.4 Service Portfolio
13.4.5 Recent Developments
13.5 Icon Plc
13.5.1 Company Snapshot
13.5.2 Revenue Analysis
13.5.3 Company Share Analysis
13.5.4 Service Portfolio
13.5.5 Recent Developments
13.6 Image Core Lab
13.6.1 Company Snapshot
13.6.2 Service Portfolio
13.6.3 Recent Development
13.7 Anagram 4 Clinical Trials
13.7.1 Company Snapshot
13.7.2 Service Portfolio
13.7.3 Recent Development
13.8 Bioclinica
13.8.1 Company Snapshot
13.8.2 Service Portfolio
13.8.3 Recent Developments
13.9 Cardiovascular Imaging Technologies
13.9.1 Company Snapshot
13.9.2 Product Portfolio
13.9.3 Recent Development
13.10 Ert Clinical
13.10.1 Company Snapshot
13.10.2 Service Portfolio
13.10.3 Recent Developments
13.11 Intrinsic Imaging
13.11.1 Company Snapshot
13.11.2 Product Portfolio
13.11.3 Service Portfolio
13.11.4 Recent Developments
13.12 Lyscaut Medical Imaging Company
13.12.1 Company Snapshot
13.12.2 Service Portfolio
13.12.3 Recent Development
13.13 Parexel International Corporation
13.13.1 Company Snapshot
13.13.2 Service Portfolio
13.13.3 Recent Developments
13.14 Perspectum Diagnostics
13.14.1 Company Snapshot
13.14.2 Product Portfolio
13.14.3 Service Portfolio
13.14.4 Recent Developments
13.15 Quotient Sciences
13.15.1 Company Snapshot
13.15.2 Service Portfolio
13.15.3 Recent Developments
13.16 Radiant Sage Llc
13.16.1 Company Snapshot
13.16.2 Product Portfolio
13.16.3 Service Portfolio
13.16.4 Recent Developments
13.17 Worldcare Clinical
13.17.1 Company Snapshot
13.17.2 Service Portfolio
13.17.3 Recent Developments
14 Questionnaire
15 Related Reports

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook